Shares in CVS Group Plc (AIM:CVSG) were little moved by its #trading update, with analysts saying there was little new news, as the big news remains the ongoing Competition and Markets Authority review of the veterinary services sector. Revenue growth was up 11.9% in the four-month period to 31 October and EBITDA margins were in line with a year ago at roughly 19%. The group also announced four new acquisitions and drew attention to the launched of its new clinical governance framework, "demonstrating our commitment to driving standards of care across the veterinary profession". The #shares were down less than 0.5% at 1,492p on the morning of the update. Analysts at #Liberum said the numbers were tracking in line with consensus expectations. "That aside there wasn’t much in the way of new information. More at #Proactive #ProactiveInvestors #AIM #CVSG #CVS #CVSGroup http://ow.ly/4g9f105451A
